NDC 59762-0073-01 - Hydrocortisone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-0073
- Requested NDC
- 59762-0073-01
- Package NDCs from labels
- 59762-0073-1, 59762-0073-01
- Manufacturer
- Mylan Pharmaceuticals Inc. | Pfizer Inc | Pharmacia & Upjohn Company LLC
- Effective date
- 2026-05-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone tablets, USP | Mylan Pharmaceuticals Inc. | Pfizer Inc | Pharmacia & Upjohn Company LLC | 2026-05-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Hydrocortisone - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2022-10-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-0073-1 | Hydrocortisone | 50 in 1 BOTTLE | TABLET | 50 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-0073 | HYDROCORTISONE TABLET [MYLAN PHARMACEUTICALS INC.] | 10 | Current NDC, Legacy NDC, 1 package rows | 20250523_bc751403-94f2-4f9d-b533-cf6186a40ceb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-0073-1 | EA - Each | 59762-0073 | edb93ebf-77b2-4475-8aaa-7b0ad03a4677 | 1 | 2013-03-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDROCORTISONE | ACTIVE INGREDIENT | WI4X0X7BPJ | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 | |
| HYDROCORTISONE | ACTIVE MOIETY | WI4X0X7BPJ | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 | |
| CALCIUM STEARATE | INACTIVE INGREDIENT | 776XM7047L | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | HYDROCORTISONE TABLET [GREENSTONE LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Appetrol 20 | FUCUS VESICULOSUS, CHELIDONIUM MAJUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, QUERCUS GLANDIUM SPIRITUS, QUERCUS ROBUR, NUX VOMICA, PHYTOLACCA DECANDRA, ORNITHOGALUM UMBELLATUM, AGNUS CASTUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, SACCHARUM OFFICINALE, SOLIDAGO VIRGAUREA, CALCAREA CARBONICA, CARBO VEGETABILIS, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, SINAPIS ARVENSIS, FLOS, UBIDECARENONUM, GRAPHITES, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, HYPOTHALAMUS (BOVINE) | Carbalor LLC | d66234a3-2477-42be-8f7b-283e3a5f87ed | 2026-03-12 | Warnings | C151H8M554 |
| Hydrocortisone 1% | HYDROCORTISONE | ProStat First Aid | 4cd62cba-075a-7448-e063-6394a90ab48d | 2026-03-12 | Warnings | WI4X0X7BPJ |
| Hydrocortisone | HYDROCORTISONE | Strides Pharma Science Limited | 90a46849-5b75-467b-9bc5-8f192d4d20d2 | 2026-03-11 | Warnings, Adverse reactions | 197782 197787 197783 WI4X0X7BPJ |
| HYDROCORTISONE | HYDROCORTISONE | DIRECT RX | 3d017594-3a00-40ba-b392-1699992fa1b1 | 2026-03-05 | Adverse reactions | WI4X0X7BPJ |
| Hydrocortisone Cream | HYDROCORTISONE CREAM | Direct_Rx | 19b09776-165a-9579-e063-6294a90a9d39 | 2026-03-05 | Adverse reactions | WI4X0X7BPJ |
| Hydrocortisone 1% | HYDROCORTISONE | Trifecta Pharmaceuticals Usa Llc | f4d4a56b-b4b7-9a07-e053-2a95a90ad853 | 2026-03-04 | Warnings | WI4X0X7BPJ |
| Hydrocortisone 1% | HYDROCORTISONE | Trifecta Pharmaceuticals Usa Llc | 9987165c-1a0f-dd57-e053-2a95a90ae735 | 2026-03-04 | Warnings | WI4X0X7BPJ |
| HYDROCORTISONE | HYDROCORTISONE 1% | PHARMACY CHOICE INC | 4cdfe8b6-c332-7bf8-e063-6394a90abaec | 2026-03-03 | Warnings | WI4X0X7BPJ |
| Cortenema | HYDROCORTISONE | ANI Pharmaceuticals, Inc. | a307448a-ccc4-41a8-977a-11f28f0bded9 | 2026-03-02 | Warnings, Adverse reactions | WI4X0X7BPJ |
| Procto-Med HC | HYDROCORTISONE | NuCare Pharmaceuticals,Inc. | 4b972547-5bd4-155d-e063-6394a90a03ee | 2026-03-02 | Adverse reactions | WI4X0X7BPJ |
| Hydrocortisone | HYDROCORTISONE | ANI Pharmaceuticals, Inc. | 40654d12-56e4-4489-be49-19c60ad918ad | 2026-03-02 | Warnings, Adverse reactions | WI4X0X7BPJ |
| Mineral Oil | MINERAL OIL | Chain Drug Marketing Association | 3bfdad9c-ac58-4e92-b952-555e8a8351cd | 2026-02-27 | Warnings, Adverse reactions | T5L8T28FGP |
| Hydrocortisone | HYDROCORTISONE | PD-Rx Pharmaceuticals, Inc. | 931ed426-89a1-4877-a4a5-cb963d51e717 | 2026-02-25 | Warnings, Adverse reactions | 197782 197787 197783 WI4X0X7BPJ |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | A-S Medication Solutions | 1185a82b-e731-456a-8fc1-d9f0fc1ab0bc | 2026-02-24 | Warnings, Adverse reactions | WI4X0X7BPJ |
| Mineral Oil | MINERAL OIL | Better Living Brands, LLC | 7f2f1b30-497a-4c53-accc-8455169b17b3 | 2026-02-24 | Warnings, Adverse reactions | T5L8T28FGP |
| Hydrocortisone | HYDROCORTISONE | A-S Medication Solutions | a3fbdae4-d1dc-42de-939f-f9a7aab60e49 | 2026-02-24 | Adverse reactions | WI4X0X7BPJ |
| Hydrocortisone | HYDROCORTISONE | Sportpharm LLC | 9578b39e-3df7-4d75-abd7-f1d5524545e5 | 2026-02-23 | Warnings | WI4X0X7BPJ |
| Mineral Oil | MINERAL OIL | Perrigo Direct, Inc | f1656280-fad9-4922-9d5c-be774a8b1422 | 2026-02-19 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Meijer, Inc. | 652d1da9-a71f-4113-9ef3-da0916724625 | 2026-02-19 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Target Corporation | 526508f0-e908-4e3d-88f5-404a95f6de76 | 2026-02-18 | Warnings, Adverse reactions | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.